1996
DOI: 10.1016/0166-3542(95)00906-x
|View full text |Cite
|
Sign up to set email alerts
|

New arylpyrido-diazepine and -thiodiazepine derivatives are potent and highly selective HIV-1 inhibitors targeted at the reverse transcriptase

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
14
0

Year Published

2006
2006
2021
2021

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 27 publications
(14 citation statements)
references
References 46 publications
0
14
0
Order By: Relevance
“…The title compound may be used as a precursor for obtaining bioactive molecules with antitumor activity, see: Bellarosa et al (1996). For the biological activity of benzofuropyrimidine derivatives, see: Moneam et al (2004); Bodke & Sangapure (2003).…”
Section: Related Literaturementioning
confidence: 99%
“…The title compound may be used as a precursor for obtaining bioactive molecules with antitumor activity, see: Bellarosa et al (1996). For the biological activity of benzofuropyrimidine derivatives, see: Moneam et al (2004); Bodke & Sangapure (2003).…”
Section: Related Literaturementioning
confidence: 99%
“…The title compound may be used as a precursor for obtaining bioactive molecules, see: Bellarosa et al (1996). For the biological activity of benzofuropyrimidine derivatives, see: Moneam et al (2004); Bodke et al (2003); Palacios et al (2007); Duval et al (2005); Teimouria et al (2006).…”
Section: Related Literaturementioning
confidence: 99%
“…Nevirapine (116), a dipyrido-1,4-diazepine compound (Fig. Bellorosa et al reported on arylpyridodiazepine (117) and it was found to inhibit human immunodeficiency virus type I [HIV-1(IIIB)] replication at a concentration of 0.003-0.04 M without being cytotoxic at a 3,000-15,000 fold higher concentration [159]. Bellorosa et al reported on arylpyridodiazepine (117) and it was found to inhibit human immunodeficiency virus type I [HIV-1(IIIB)] replication at a concentration of 0.003-0.04 M without being cytotoxic at a 3,000-15,000 fold higher concentration [159].…”
Section: Non-nucleoside Reverse Transcriptase Inhibitors (Nnrtis) Conmentioning
confidence: 99%